Ceribell, Inc. (CBLL) bonds
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$26.14−0.21 (-0.80%)
Close on Nov 13, 2026Market cap $1.00BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$19.98M
Long-term debt
Net debt
-$12.68M
After $32.66M of cash
Implied interest rate
9.60%
FY2025 interest ÷ average debt
Interest coverage
-30.9×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Ceribell's 10-Q for the period ended Feb 6, 2024
Ceribell's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Expires |
|---|---|---|
| Venture Loan and Security Agreement (VLSA) | $20.00M | Mar 1, 2029 |
| Horizon Technology Finance Corporation (Horizon) | $14.00M | – |
| Revolving line of credit | $10.00M | – |
| Silicon Valley Bank (SVB) | $6.00M | – |
| Term loan | $50.00M | – |
See a number that looks wrong?